Skip to content

FreeStyle Libre 3Recalls & reported problems across all models

Abbott Diabetes Care Inc · 14 models in the FDA device registry

Data updated Oct 18, 2026 from official FDA records · Editorial policy

5 open recalls name at least one FreeStyle Libre 3 model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.

Adverse event reports
69,860
Deaths reported
2
Injuries reported
2,849
Recalls
6

We found 14 models of FreeStyle Libre 3 by Abbott Diabetes Care Inc in the FDA's device registry (GUDID). Together they are named in 69,860 adverse event reports in the FDA's MAUDE database, received between Oct 4, 2022 and Sep 30, 2026 — classified as 2 deaths, 2,849 injuries, 67,006 malfunctions.

The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (45,841 reports).

6 FDA recall records name at least one of these models by its device identifier, 5 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 116 reportsDec 2023: 118 reportsJan 2024: 124 reportsFeb 2024: 122 reportsMar 2024: 137 reportsApr 2024: 198 reportsMay 2024: 137 reportsJun 2024: 68 reportsJul 2024: 52 reportsAug 2024: 59 reportsSep 2024: 76 reportsOct 2024: 53 reportsNov 2024: 44 reportsDec 2024: 41 reportsJan 2025: 98 reportsFeb 2025: 139 reportsMar 2025: 194 reportsApr 2025: 211 reportsMay 2025: 325 reportsJun 2025: 384 reportsJul 2025: 562 reportsAug 2025: 485 reportsSep 2025: 345 reportsOct 2025: 417 reportsNov 2025: 489 reportsDec 2025: 1,827 reportsJan 2026: 2,094 reportsFeb 2026: 841 reportsMar 2026: 1,844 reportsApr 2026: 13,355 reportsMay 2026: 7,603 reportsJun 2026: 2,636 reportsJul 2026: 5,905 reportsAug 2026: 13,009 reportsSep 2026: 14,656 reportsOct 2026: 0 reports20242025202614,656
Last 36 months. The most recent month may be incomplete.

FreeStyle Libre 3 recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

  1. Nov 24, 2025Class IOpen, Classified

    Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results

    Z-1023-2026 · Root cause: Process control · Recall details · FDA record ↗

  2. Nov 24, 2025Class IOpen, Classified

    Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results

    Z-1022-2026 · Root cause: Process control · Recall details · FDA record ↗

  3. Nov 24, 2025Class IOpen, Classified

    Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results

    Z-1021-2026 · Root cause: Process control · Recall details · FDA record ↗

  4. Nov 24, 2025Class IOpen, Classified

    Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results

    Z-1020-2026 · Root cause: Process control · Recall details · FDA record ↗

  5. Jul 24, 2024Class IOpen, Classified

    Users of the FreeStyle Libre 3 sensors reported situations where they were receiving erroneously high glucose results. The inaccurate higher glucose values may lead to users calculating higher insulin bolus correctional doses based on inaccurate CGM glucose data. The inaccurate higher glucose values may also contribute to missed or delayed recognition of hypoglycemia, when the sensor incorrectly reports normal or even high glucose values when the actual glucose is trending low or is low. If the hypoglycemia missed by the device occurs acutely, a user may not be able to confirm the actual glucose with a self-monitored blood glucose (BG) and/or administer prompt intervention to raise glucose levels. The over-delivery of insulin and/or the missed or delayed detection of impending or overt hypoglycemia in the worst-case scenario may lead to severe hypoglycemia/hypoglycemic crisis with significant adverse health consequences. Such consequences include central nervous system dysfunction, loss of consciousness, seizure activity and may lead to coma, permanent neurological damage, and death.

    Z-2692-2024 · Root cause: Process design · Recall details · FDA record ↗

  6. Feb 9, 2023Class IICompleted

    If using affected glucose monitoring app on Android 13 Operating System, extended periods of signal loss may be experienced, due to app not connected, which could impact ability to receive glucose reading/alarms, which could lead to undetected low or high glucose, which could result in delayed treatment: not taking insulin (for high glucose), or not taking glucose (for low glucose) when required.

    Z-0734-2024 · Root cause: Software design · Recall details · FDA record ↗

Most reported FreeStyle Libre 3 problems

Device problems

  • Incorrect, Inadequate or Imprecise Result or Readings45,841
  • Low Readings19,724
  • Device Alarm System1,332
  • Detachment of Device or Device Component878
  • Device Displays Incorrect Message619
  • Unable to Obtain Readings619
  • High Readings413
  • Adverse Event Without Identified Device or Use Problem384

Patient problems

  • No Clinical Signs, Symptoms or Conditions66,516
  • Hypoglycemia877
  • Loss of consciousness722
  • Device Embedded In Tissue or Plaque672
  • Hyperglycemia561
  • Insufficient Information344
  • Dizziness297
  • Skin Infection238

FreeStyle Libre 3 models

14 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent FreeStyle Libre 3 adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Abbott Diabetes Care Inc products

All Abbott Diabetes Care Inc devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page